HR 7971 116th Congress House

EVALUATE Act

Official title: To direct the Food and Drug Administration to solicit and consider the recommendations of the Vaccines and Related Biological Products Advisory Committee befor… Show full official titleShow less

Introduced: August 7, 2020 Introduced by: Krishnamoorthi, Raja Democratic · Illinois See on congress.gov

Health Advisory bodiesCardiovascular and respiratory healthDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulation

More subjectsShow fewer subjects

Emergency medical services and trauma careFood and Drug Administration (FDA)Government information and archivesImmunology and vaccinationInfectious and parasitic diseasesLicensing and registrationsMedical researchPublic participation and lobbying

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Aug 7, 2020

Introduced in House

Aug 7, 2020

Referred to the House Committee on Energy and Commerce.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action August 7, 2020

Referred to the House Committee on Energy and Commerce.

Plain-English summary Congressional Research Service

Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act or the EVALUATE Act

This bill requires the Food and Drug Administration, before licensing or authorizing any COVID-19 (i.e., coronavirus disease 2019) vaccine, to receive advisory committee recommendations concerning the vaccine's safety and effectiveness.

Bill text 1 version